CMT Research Foundation (CMTRF), a patient-led, non-profit focused on delivering treatments and cures for Charcot-Marie-Tooth (CMT) disease, today announced that Santo Caivano, Director, Customer Engagements of Cisco’s CAP (Critical Accounts Program) Americas team, has joined the Foundation’s Board of Directors.
“There is not another organization that has advanced the science of finding a cure for CMT more than the CMT Research Foundation,” says Mr. Caivano. “I am pleased to be part of such a progressive and focused team.”
Mr. Caivano leads a team of Crisis and Escalation Managers dedicated to resolving the most complex and critical problems of Cisco customers. He joined Cisco in March 2011 as Cisco acquired Inlet Technologies, a company where he was a principal and led Product Management, Professional Services, and Technical Services. Prior to Inlet Technologies, Mr. Caivano spent over a decade leading teams in several successful start-ups, including three that were acquired and one that went public. Earlier in his career, Mr. Caivano worked at IBM. He holds a bachelor’s degree in industrial relations from the University of North Carolina, an Executive Certificate in Leadership from the University of Notre Dame and he completed eCornell’s Diversity, Equity, and Inclusion program.
“Santo has been active in nonprofit and community-based service organizations for a decade. He brings the Board a wealth of strategic thinking and is a hands-on experienced executive. We are lucky to have him at CMTRF,” says Patrick Livney, Chair of the Foundation’s Board of Directors.